2023. The impact of tralokinumab on quality of life and school in patients aged 12-17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s139. DOI:https://doi.org/10.25251/skin.7.supp.139.